Israeli startup CytoReason raises $80M to expand AI model, hub Massachusetts
Israeli startup CytoReason, maker of a computation model to map and complice treatments, announced it secured $80 million funding. Pfizer, ...
Tag: CytoReason
Israeli startup CytoReason, maker of a computation model to map and complice treatments, announced it secured $80 million funding. Pfizer, ...
